Skip to content

CalAmp CAMP EBITDA margin

EBITDA margin at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-32%-10.7pp
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-572.1%-593pp
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-552.3%-191pp
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
-1,759.7%+1,470pp
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
-181.5%-206pp
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-46.5%-1.0pp

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Calculated from CalAmp’s reported figures.

Based on trailing twelve months.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's EBITDA margin?
CalAmp (CAMP) reported EBITDA margin of -1,291% in Q1 2026.
How has CalAmp's EBITDA margin changed year-over-year?
CalAmp's EBITDA margin increased by 62.2% year-over-year, from -3,419.3% to -1,291%.
What does EBITDA margin mean?
EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.